Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Prolymphocytic × Pharmacogenomic Testing × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Malignant Tumor of Ill-defined Site 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1

Interventions

fludarabine phosphate 20 Mycophenolic Acid 15 Whole-Body Irradiation 14 Peripheral Blood Stem Cell Transplantation 11 Cyclophosphamide 11 Cyclosporine 10 Cyclosporins 8 fludarabine 7 Tacrolimus 7 Rituximab 7 Antilymphocyte Serum 7 Busulfan 6 Sirolimus 4 Melphalan 4 Methotrexate 3 Cytarabine 3 Cord Blood Stem Cell Transplantation 3 pegfilgrastim 2 ibrutinib 2 Thiotepa 2 Oxaliplatin 2 Filgrastim 2 Etoposide 2 Darbepoetin alfa 2 thymoglobulin 1 selinexor 1 ofatumumab 1 immunotoxin HA22 1 ferrous sulfate 1 ferric gluconate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡